Prevention primaire et secondaire chez les femmes a haut risque de cancer mammaire.

Breast Neoplasms/genetics/prevention & control; Female; Genetic Predisposition to Disease; Humans; Primary Prevention; Risk Reduction Behavior; Secondary Prevention

Abstract :

[en] Many factors determine a woman's risk of breast cancer; some genetic are related to family history, others are based on personal factors such reproductive and medical history. A high-risk woman must benefit of a specific screening regimen including breast examination, mammography, ultrasonography and contrast material-enhanced magnetic resonance. But she can also benefit of chemo prevention or/and risk-reducing surgery such bilateral prophylactic salpingo-oophorectomy and bilateral prophylactic mastectomy.

Disciplines :

Reproductive medicine (gynecology, andrology, obstetrics)

Author, co-author :

BLERET, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

DESREUX, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Cusumano, P

HERMAN, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Kridelka, Frédéric ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie et obstétrique

REMACLE, Nicole

THILLE, Alain ; Centre Hospitalier Universitaire de Liège - CHU > Imagerie abdominale

LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Language :

French

Title :

Prevention primaire et secondaire chez les femmes a haut risque de cancer mammaire.

Alternative titles :

[en] Primary and secondary prevention for women at high risk for breast cancer

Publication date :

2011

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6

Pages :

245-9

Peer reviewed :

Peer reviewed

Available on ORBi :

since 26 December 2014

Statistics

Number of views

277 (3 by ULiège)

Number of downloads

501 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Antoniou A, Pharoah PD, Narod S, et al. - Average risks of breast and ovarian cancer associated with BRAC1 or BRCA2 mutations detected in case series unselected for family history : a combined analysis of 22 studies. Am J Hum Genet, 2003, 72, 1117-1130. (Pubitemid 36530000)
Tyrer J, Duffy SW, Cuzick J. - A breast cancer prediction model incorporating familial and personal risk factors. Stat Med, 2004, 23, 1111-1130. (Pubitemid 38477070)
Atchley DP, Albarracin CT, Lopez A, et al. - Clinical and pathological characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol, 2008, 26, 4282-4288.
Warner E, Plewes DB, Hill KA, et al. - Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA, 2004, 292, 1317-1325. (Pubitemid 39223222)
Leach MO, Boggis CR, Dixon AK, et al. - Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer : a prospective multicentre cohort study (MARIBS). Lancet, 365, 1769-1778.
Kuhl Chrading S, Leutner CC, et al. - Mammography, breast ultrasound and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol, 2005, 23, 8469-8476.
Kriege M, Brekelmans CT, Boetes C, et al. - Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med, 2004, 351, 427-437.
Sardanelli F, Podo F, D'Agnolo G, et al. - Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study) : interim results. Radiology, 2007, 242, 698-715.
Kriege M, Brekelmans CT, Peterse H, et al. - Tumor characterisics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat, 2007, 102, 357-363. (Pubitemid 46474846)
van der Velde NM, mourits MJ, Arts H, et al. - Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer, 2009, 124, 919-923.
Olivier Ri,Lubsen-Brandsma MA, Verhoefs, et al. - CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol, 2006, 100, 20-26.
Callahan MJ, Crum CP, Meideros F, et al. - Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol, 2007, 25, 3985-3990. (Pubitemid 47477278)
Rabban JT, Barnes M, Chen LM, et al. - Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol, 2009, 33, 1125-1136.
Domchek SM, Friebel TM, Singer CF, et al. - Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 2010, 304, 967-975.
Shuster LT, Gostout BS, Grossardt BR, et al. - Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int, 2008, 14, 111-116.
Rebbeck TR, Friebel T, Lynch HT, et al. - Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers : the PROSE Study Group. J Clin Oncol, 2004, 22, 1055-1062. (Pubitemid 41095038)
Cuzick J. - IBIS II : a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. Expert Rev Anticancer Ther, 2008, 8, 1377-1385.
Cuzick J. - Chemoprevention of breast cancer. Breast Cancer, 2008, 15, 10-16.
Lahmann PH, Schulz m, Hoffman K, et al. - Long-term weight change and breast cancer risk : the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer, 2005, 93, 582-589.
Lynch BM, Neilson HK, Friedenreich CM. - Physical activity and breast cancer prevention. Recent Results Cancer Res, 2011, 186, 13-42.